Clive K. Fields, MD

The VillageMD Walgreens Entanglement

Co-Founder & CMO, VillageMD

Primary Care ConsolidationHouston, TX

Overview

Co-founded VillageMD in 2013, which became majority-owned by Walgreens Boots Alliance, then participated in a $8.9B acquisition of Summit Health-CityMD with Cigna/Evernorth taking a minority stake. Walgreens was subsequently acquired by private equity firm Sycamore Partners for $10B+, making VillageMD a standalone PE-owned entity. His committee role gives him influence over the Medicare payment policy that drives VillageMD's value-based contracts.

Career Arc

Professional Timeline

2013–Present

Co-Founder & CMO

VillageMD

Physician executive

Accountable Care Coalition of Texas

Inherited Village Family Practice

Founded 1975, Houston

Associate Professor

Baylor College of Medicine and UT Houston

Business Interests & Affiliations

  • VillageMD — 680+ locations, 20,000 employees post-Summit acquisition.
  • Walgreens majority ownership → $8.9B Summit Health-CityMD acquisition with Cigna/Evernorth minority stake.
  • 2025: Sycamore Partners acquires Walgreens, VillageMD becomes standalone PE entity.
  • Three-time Modern Healthcare "100 Most Influential." AAFP Physician Executive of the Year 2018.

Red Flags

Conflicts & Concerns

Co-founded what became a $9B acquisition target, now PE-owned. Committee role gives influence over Medicare payment policy driving VillageMD's contracts.

VillageMD's entire business model is Medicare Advantage risk-based primary care — exactly what the committee is chartered to advise on.

Cigna/Evernorth minority stake means the nation's second-largest insurer has a financial interest in VillageMD's policy outcomes.

Physician-Owned Hospital Relevance

VillageMD represents the aggregation of independent primary care practices into corporate platforms under MA value-based contracts — the model that displaces physician-owned independent practice. No stated interest in physician ownership restoration.

Sources

  1. Walgreens-VillageMD-Summit Health $9B Deal
  2. Sycamore-Walgreens Acquisition
  3. Health Evolution Bio